Brief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
29/05/2026 13:04
BRIEF-Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed May 29 (Reuters) - Aptose Biosciences Inc APS.TO:
ANNOUNCES UPDATE ON ANTICIPATED TIMING OF CLOSING OF THE PLAN OF ARRANGEMENT WITH HANMI PHARMACEUTICAL
CLOSING OF ARRANGEMENT WITH HANMI PHARMACEUTICAL FURTHER DELAYED AS CERTAIN KOREAN REGULATORY APPROVALS IN PROGRESS
Source text: ID:nGNXkThXM
Further company coverage: APS.TO
((Reutersbriefs@thomsonreuters.com;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting